Logo of the International Congress on Porphyrins and Porphyrias 2015

International Congress on Porphyrins and Porphyrias

Sept 14th – Sept 16th 2015, Düsseldorf, Germany

Scientific Program for Wednesday September 16th, 2015

Theme: Evolving concepts in pathogenesis, clinic and therapy of the porphyrias / Miscellaneous

Session 9

Chair: Aasne K. Arsand (Norway) and Robert J. Desnick (USA)

09:00 - 09:45
Plenary lecture 8: »The role of cellular metabolites in heme synthesis.«
Harry A. Dailey, USA
 
09:45 - 10:45
Selected oral presentations
 
 
26. Molecular and kinetic characterisation of wild type and mutant human porphobilinogen deaminase.
Elaine Pienaar et al., South Africa
 
 
27. Markers of endothelial dysfunction in patients with acute porphyrias.
Paolo Ventura et al., Italy
 
 
28. Systemic inflammation revealed by plasma biomarkers in acute intermittent porphyria.
Ole-Lars Brekke et al., Norway
 
 
29. Psychosocial issues in acute porphyria: A qualitative study of the perspectives of patients.
Hetanshi Naik et al., USA
 
10:45 - 11:15
Coffee break
 

Session 10

Chair: Laurent Gouya (France) and Alcira Batlle (Argentina)

11:15 - 12:00
Plenary lecture 9: »A paradigm shift in understanding porphyrias: prospecting for drug innovations and disease outcomes through the lens of structural biology.«
C.S. Raman, USA
 
12:00 - 12:45
Selected oral presentations
 
 
30. Characterisation of the functional role of variants within the regulatory regions of UROD and CPOX genes.
Valeria Fiorentino et al., Italy
 
 
31. Non-invasive measurement of mitochondrial health in porphyria.
Ashwani Singal et al., USA
 
 
32. Dental health in acute intermittent porphyria: a case control study.
Elin Storjord et al., Norway
 
12:45 - 13:00
Future meetings / Closing remarks / Farewell and end of the meeting